This inventor holds 2 USPTO granted patents. Top assignees: Medac Gesellschaft Fur Klinische Spezialpraparate Mbh, Other. Active years: 1998-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 17 
1 out of 834,513 Years Active: 1998-2000
Title: Bernhard Schlott: Innovator in Staphylokinase Research
Introduction
Bernhard Schlott is a notable inventor based in Jena, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of recombinant staphylokinases. His work has implications for medical applications, especially in the area of thrombolysis.
Latest Patents
Bernhard Schlott holds 2 patents. His latest patents include the invention titled "Expression of signal-peptide-free staphylokinases." This invention relates to recombinant staphylokinase polypeptides that exhibit a plasminogen activator effect. The polypeptides are produced by expressing DNA sequences that are devoid of signal-peptide-coding regions.
Career Highlights
Throughout his career, Bernhard has worked with Medac Gesellschaft für Klinische Spezialpräparate mbH, a company known for its clinical specialty preparations. His innovative work in staphylokinases has positioned him as a key figure in this specialized field.
Collaborations
Bernhard has collaborated with notable professionals such as Sybille Albrecht and Karl-Heinz Guhrs. Their combined expertise has contributed to advancements in the research and application of staphylokinases.
Conclusion
Bernhard Schlott's contributions to the field of biochemistry, particularly through his patents and collaborations, highlight his role as an innovator in staphylokinase research. His work continues to influence medical science and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile